Cardiomyopathy — Cardiac Assessment of Patients With Hip Implants
Citation(s)
Afolaranmi GA, Akbar M, Brewer J, Grant MH Distribution of metal released from cobalt-chromium alloy orthopaedic wear particles implanted into air pouches in mice. J Biomed Mater Res A. 2012 Jun;100(6):1529-38. doi: 10.1002/jbm.a.34091. Epub 2012 Mar 15.
Alexander CS Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. Am J Med. 1972 Oct;53(4):395-417.
Back DL, Young DA, Shimmin AJ How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop Relat Res. 2005 Sep;438:177-81.
Ball ST, Severns D, Linn M, Meyer RS, Swenson FC What happens to serum metal ion levels after a metal-on-metal bearing is removed? J Arthroplasty. 2013 Sep;28(8 Suppl):53-5. doi: 10.1016/j.arth.2013.06.040. Epub 2013 Aug 12.
Baur LH Early detection of iron overload in the heart: a key role for MRI! Int J Cardiovasc Imaging. 2009 Dec;25(8):789-90. doi: 10.1007/s10554-009-9538-y. Epub 2009 Nov 24.
Brock T, Stopford W Bioaccessibility of metals in human health risk assessment: evaluating risk from exposure to cobalt compounds. J Environ Monit. 2003 Aug;5(4):71N-76N. Review.
CARTWRIGHT GE The relationship of copper, cobalt, and other trace elements to hemopoiesis. Am J Clin Nutr. 1955 Jan-Feb;3(1):11-9.
Chu WC, Au WY, Lam WW MRI of cardiac iron overload. J Magn Reson Imaging. 2012 Nov;36(5):1052-9. doi: 10.1002/jmri.23628. Review.
Cohen D How safe are metal-on-metal hip implants? BMJ. 2012 Feb 28;344:e1410. doi: 10.1136/bmj.e1410.
De Haan R, Pattyn C, Gill HS, Murray DW, Campbell PA, De Smet K Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br. 2008 Oct;90(10):1291-7. doi: 10.1302/030
Ebreo D, Khan A, El-Meligy M, Armstrong C, Peter V Metal ion levels decrease after revision for metallosis arising from large-diameter metal-on-metal hip arthroplasty. Acta Orthop Belg. 2011 Dec;77(6):777-81.
Hart AJ, Skinner JA, Henckel J, Sampson B, Gordon F Insufficient acetabular version increases blood metal ion levels after metal-on-metal hip resurfacing. Clin Orthop Relat Res. 2011 Sep;469(9):2590-7. doi: 10.1007/s11999-011-1930-y. Epub 2011 Jun 9.
KRISS JP, CARNES WH, GROSS RT Hypothyroidism and thyroid hyperplasia in patients treated with cobalt. J Am Med Assoc. 1955 Jan 8;157(2):117-21.
Langton DJ, Jameson SS, Joyce TJ, Webb J, Nargol AV The effect of component size and orientation on the concentrations of metal ions after resurfacing arthroplasty of the hip. J Bone Joint Surg Br. 2008 Sep;90(9):1143-51. doi: 10.1302/0301-620X.90B9.2078
Machado C, Appelbe A, Wood R Arthroprosthetic cobaltism and cardiomyopathy. Heart Lung Circ. 2012 Nov;21(11):759-60. doi: 10.1016/j.hlc.2012.03.013. Epub 2012 Apr 18.
Mao X, Wong AA, Crawford RW Cobalt toxicity--an emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust. 2011 Jun 20;194(12):649-51.
Merritt K, Brown SA Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J Biomed Mater Res. 1995 May;29(5):627-33.
Newton AW, Ranganath L, Armstrong C, Peter V, Roberts NB Differential distribution of cobalt, chromium, and nickel between whole blood, plasma and urine in patients after metal-on-metal (MoM) hip arthroplasty. J Orthop Res. 2012 Oct;30(10):1640-6. doi: 1
Oldenburg M, Wegner R, Baur X Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty. 2009 Aug;24(5):825.e15-20. doi: 10.1016/j.arth.2008.07.017. Epub 2008 Oct 2.
Pelclova D, Sklensky M, Janicek P, Lach K Severe cobalt intoxication following hip replacement revision: clinical features and outcome. Clin Toxicol (Phila). 2012 Apr;50(4):262-5. doi: 10.3109/15563650.2012.670244.
Steens W, von Foerster G, Katzer A Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip--a case report. Acta Orthop. 2006 Oct;77(5):830-2.
Tower SS Arthroprosthetic cobaltism associated with metal on metal hip implants. BMJ. 2012 Jan 17;344:e430. doi: 10.1136/bmj.e430.
Tower SS Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am. 2010 Dec 1;92(17):2847-51. doi: 10.2106/JBJS.J.00125. Epub 2010 Oct 29.
van Lingen CP, Ettema HB, Timmer JR, de Jong G, Verheyen CC Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels. Hip Int. 2013 Sep-Oct;23(5):441-4. doi: 10.5301/hipint.5000054. Epub 2013
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.